SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has emerged as a pandemic. Paucity of information concerning the virus and therapeutic interventions have made SARS-CoV-2 infection a genuine threat to global public health. Therefore, there is a growing need for underst...
Guardado en:
Autores principales: | Md Zobaer Hasan, Syful Islam, Kenichi Matsumoto, Taro Kawai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a81831179b2b48a58cf0edd6bf8cccbf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
por: Jamal Majidpoor, et al.
Publicado: (2022) -
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression
por: Arianna Calcinotto, et al.
Publicado: (2018) -
Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response
por: Marius Piepke, et al.
Publicado: (2021) -
Transcription factor enrichment analysis (TFEA) quantifies the activity of multiple transcription factors from a single experiment
por: Jonathan D. Rubin, et al.
Publicado: (2021) -
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections
por: Alan Bénard, et al.
Publicado: (2021)